MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. This process involves various stages, including cultivation, processing, packaging, distribution, and retailing.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

SEPTEMBER 22, 2020

The cannabis that was approved for medical use was required to have a low THC content, and patients had to register their use of the substance on the Compassionate Use Registry, arguably a violation of their privacy. The 2016 law also established more Medical Marijuana Treatment Centers, making it easier for patients to access cannabis.

Edibles 52

Edibles Patients Chronic Pain Conditions 52

Cannabis Law Report

JANUARY 31, 2022

Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

LifeCannMD

MAY 11, 2022

So how has it come to be that Florida physicians are able to give patients that qualify a “recommendation” for Medical Marijuana? . It started in June of 2014, when Florida became the 22nd state to partially legalize access to medical marijuana through the Compassionate Medical Cannabis Act of 2014.

Law 52

Law Marijuana Patients Epilepsy 52

Cannabis Law Report

NOVEMBER 2, 2021

tetrahydrocannabidiol (THC) and it will have to be imported already packaged and ready for exclusive distribution in pharmacies and drug stores, according to the resolution. The medicine, a cannabidiol (CBD) -based oral solution, It is the fourth with this active principle whose use is authorized in Brazil.

Medicine 52

Medicine Chronic Pain Epilepsy Marijuana 52

Cannabis Law Report

JANUARY 27, 2022

The proposed rules, which also cover labeling and packaging, are currently before the World Trade Organization (WTO), where member countries have until late February to submit comments. The new rules will also require child-resistant packaging, plus: Labeling that better identifies active ingredients.

Packaging 52

Packaging Compliance Compliance Access 52

Cannabis Law Report

JUNE 9, 2021

(“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the launch of Symbios, a complement to the Company’s existing medical brand portfolio in Canada. Aphria started in 2014 in Leamington, Ontario, as one of the first companies to provide access to legal, medical cannabis.

Topical 102

Topical Patients Oil Cannabinoids 102

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). Competitive benefit package includes. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

SEPTEMBER 22, 2022

SB 1186– Medicinal Cannabis Patients’ Right of Access Act. The bill’s author, Senator Scott Weiner, states this bill is a victory for seniors living with chronic illness, and will both improve patient access and help fill voids throughout the state where no cannabis license types have been authorized. FOOTNOTES. [1]

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

MARCH 2, 2022

The Products, which HYTN believes are the first of their kind to reach the Australian market, are packaged in 60mL bottles each containing 1,200 mg of cannabinoids. The Products efficiently utilize active ingredients by focusing on the science of bioavailability, ensuring patients get more of the active ingredient they have paid for.

Oil 52

Oil Cannabinoids Packaging CBD 52

Peninsula Alternative Health

FEBRUARY 22, 2018

Where can you refer to in order to regain access to the information you were provided at the dispensary? The labels on your medication feature an abundance of highly relevant information that guides your cannabis treatment experience. Unlike other treatment modalities, you’re the governing force behind your medicinal administration.

Terpenes 74

Terpenes Trichome Strains Cannabinoids 74

Cannabis Law Report

JANUARY 24, 2020

Hemp Industry Daily reports…… Another product has been approved for use under Ireland’s Medical Cannabis Access Programme (MCAP). Additionally, severe refractory (treatment-resistant) epilepsy also qualifies. Depending on the circumstances of a patient, medical cannabis may be prescribed for up to 6 months.

Oil 59

Oil Epilepsy Conditions Treatment 59

Cannabis Law Report

DECEMBER 18, 2019

CannEpil is the company’s high cannabidiol and low tetrahydrocannabinol, phytocannabinoid-derived formulation, used in the treatment of drug-resistant epilepsy. The MXP100 product is recommended for use in mild neurological disorders, inflammatory and hepatoma patients, with the latter being a cancer of the cells of the liver.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

FEBRUARY 17, 2020

I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Medicinal Genomics

JANUARY 10, 2024

We share videos of all the CannMed presentations for free in the CannMed Archives because we believe access to quality information should not be limited. Whether it is a newly discovered compound, a destructive plant pathogen, a better treatment protocol, or updated testing standards, the cannabis industry is constantly changing.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

JULY 19, 2021

LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally. MONTREAL & CALGARY, Alberta & TORONTO–(BUSINESS WIRE)– #biotechnology –Knowde Group Inc. ,

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

AUGUST 10, 2021

The acquisition combines proven high quality dried flower sales and industry-leading yields with immediate facility expansion, increased capacity, enhanced product development, key sales licences, existing provincial supply deals, and direct distribution to medical patients focused on Veterans. MONTRÉAL, Aug.

Seed-To-Sale 105

Seed-To-Sale Cultivation Patients Cannabis 105

The Cannigma

FEBRUARY 26, 2021

Like any other health treatment, before trying CBG, you should first consult with a healthcare professional who specializes in cannabis treatment in order to avoid potential contraindications and drug interactions. An additional study carried out on rodents with colitis found that CBG was effective in treating the condition.

Oil 100

Oil Terpenes Cannabinoids Extraction 100

SMPL

FEBRUARY 20, 2020

The legislation would allow patients with qualifying conditions to purchase cannabis products from licensed dispensaries. It would be a limited system, however, prohibiting patients from smoking or vaping marijuana. The legislation would allow patients with qualifying conditions to purchase cannabis products from licensed dispensaries.

Legalization 40

Legalization Marijuana Seed-To-Sale Dispensary 40

Peninsula Alternative Health

FEBRUARY 22, 2018

Where can you refer to in order to regain access to the information you were provided at the dispensary? The labels on your medication feature an abundance of highly relevant information that guides your cannabis treatment experience. Unlike other treatment modalities, you’re the governing force behind your medicinal administration.

Terpenes 40

Terpenes Trichome Strains Cannabinoids 40

Cannabis Law Report

JULY 30, 2019

For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation. There is a distinct lack of past aggregated credible, published, accessible ongoing research or case studies.

Marijuana 40

Marijuana Education Patients Research and Development 40

SpeedWeed

MARCH 14, 2021

GCAC says its Citizen Green technology provides better patient outcomes and helps researchers find qualified participants for clinical studies, which ultimately, speeds up the approval process for new medical marijuana products. Big Data Reduces Risk by Optimizing the Decision-Making Process.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

AUGUST 14, 2019

GCAC says its Citizen Green technology provides better patient outcomes and helps researchers find qualified participants for clinical studies, which ultimately, speeds up the approval process for new medical marijuana products. Big Data Reduces Risk by Optimizing the Decision-Making Process.

Data 45

Data Research and Development Marijuana Collective 45

Marijuana Packaging

FEBRUARY 27, 2018

The biggest implication (of the study) is that many of these patients may not be getting the proper dosage; they're either not getting enough for it to be effective or they're getting too much." The result is patients not being treated for their illness in an accurate and trustworthy way. The results were quite disturbing.

Extraction 52

Extraction CBD Marijuana Oil 52

Marijuana Packaging

NOVEMBER 23, 2018

Currently, New England Treatment Access (NETA) in Northampton and Cultivate Holdings in Leicester are the two spots that are selling, with the mayor of Northampton being one of the first customers. Massachusetts Recreational Sales Have Officially Begun. Massachusetts recreational cannabis sales are go. Is New Jersey Next to Legalize?

Legalization 40

Legalization Recreational Therapy Dispensary 40

Cannabis Law Report

SEPTEMBER 23, 2021

This review indicated that that vast majority of these visits (73%) were concentrated in mostly southern states without adult-use access to marijuana. In addition to the poison control calls also noted in the FDA notice, the CDC alert included a review of emergency room visits where delta-8 THC was mentioned in the primary complaint.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

APRIL 10, 2019

My sympathies go out to the patients and their families who are desperately seeking to alleviate their symptoms with medicinal cannabis. Indeed, prescriptions have been written for the products that the family attempted to bring into the country and these have been supplied to patients. We are working hard to get the right approach.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Veriheal

AUGUST 31, 2021

His device not only provides an accessible option for cannabis users who are moving away from smoking but also opens up the opportunity for unique experiences with cannabis in the same way Starbucks revolutionized how people drink coffee. . Essay Summary: Camille is a registered nurse working towards a career as a Family Nurse Practitioner.

Research and Development 108

Research and Development Supply Chain Programs Education 108

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. CBD is not listed in any of the schedules of the Regulations, so it is not controlled by the Regulations. The Regulations define a CBPM as a preparation or product that. (a)

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Veriheal

MARCH 23, 2022

” There are currently ketamine clinics operating all across the United States; however, many health insurance companies do not cover what many still consider to be alternative treatments. Enthea is expected to expand its psychedelic treatment options to include other substances, such as psilocybin and MDMA , pending FDA approval.

Therapy 82

Therapy Treatment Supply Chain Pharmaceutical 82

CannaMD

MAY 14, 2020

Florida’s medical marijuana community may soon have access to edible forms of cannabis. CannaMD has contacted Florida’s leading medical marijuana treatment centers (MMTCs) , who say they’re now just waiting on the Department of Health to issue rules regarding packaging and other essential requirements.

Edibles 105

Edibles Marijuana THC Vaping 105